Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients with metastatic colorectal cancer using first-line nivolumab. Choosing the ...

TAS-102 plus bevacizumab is cost-effective in China but not in the US or UK due to high incremental cost-effectiveness ratios (ICERs). The study uses a decision model to compare TAS-102 monotherapy ...

The league table comprises a list of healthcare interventions in ascending order (from low to high) of their incremental cost-effectiveness ratio (ICER). The ICER is frequently expressed as cost per ...

Oncologist-driven development of an electronic health record (EHR) clinical data visualization tool for prostate cancer. ADT: androgen deprivation therapy, QALY: quality-adjusted life-year, ICER: ...